Topics

Merck KAaA erleidet Rückschlag mit Avelumab - Magenkrebs-Studie floppt

08:31 EST 8 Nov 2019 | FinanzNachrichten

Rückschlag für die Pharmakonzerne Merck KGaA und Pfizer : Das gemeinsam entwickelte Medikament Avelumab scheiterte in einer Studie an Patienten mit bestimmtem Magenkrebs. Wie die beiden Unternehme...

Original Article: Merck KAaA erleidet Rückschlag mit Avelumab - Magenkrebs-Studie floppt

NEXT ARTICLE

More From BioPortfolio on "Merck KAaA erleidet Rückschlag mit Avelumab - Magenkrebs-Studie floppt"

Quick Search

Relevant Topics

Merck and Co
Merck & Co is the 7th largest pharmaceutical company in the world based on annual sales, which reached $25,236m in 2009. They have developed 14 vaccines and over 40 prescription products in the major therapeutic areas of cardiovascular disease, respi...

Pfizer
Pfizer is a global pharmaceutical company, the largest in world based on annual sales.  In 2009, annual sales were worth $45,448m. Pfizer spend £550m on R&D in the UK alone, and have colleagues in 180 countries. Lipitor, one of its produ...